Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Diabetes and brain aging: epidemiologic evidence.

Literature DB >> 15663919

Diabetes and brain aging: epidemiologic evidence.

Abstract

Increasingly, data from epidemiologic studies suggest diabetes is a risk factor in old age for brain aging, including cognitive impairment and dementia. These associations may reflect a direct effect on the brain of hyperglycemia, or the effects of the diabetes-associated comorbidities of hypertension, dyslipidemia, or hyperinsulinemia. Epidemiologic data on diabetes and brain aging are reviewed. A brief overview is also given of the physiologic mechanisms supporting the epidemiologic data.

Entities: Disease

Mesh：

Year: 2005 PMID： 15663919 DOI： 10.1007/s11892-005-0069-1

Source DB: PubMed Journal: Curr Diab Rep ISSN： 1534-4827 Impact factor: 4.810

70 in total

1. Midlife blood pressure and dementia: the Honolulu-Asia aging study.

Authors: L J Launer; G W Ross; H Petrovitch; K Masaki; D Foley; L R White; R J Havlik
Journal: Neurobiol Aging Date: 2000 Jan-Feb Impact factor: 4.673

Review 2. Insulin in the brain: a hormonal regulator of energy balance.

Authors: M W Schwartz; D P Figlewicz; D G Baskin; S C Woods; D Porte
Journal: Endocr Rev Date: 1992-08 Impact factor: 19.871

3. The rising global burden of diabetes and its complications: estimates and projections to the year 2010.

Authors: A F Amos; D J McCarty; P Zimmet
Journal: Diabet Med Date: 1997 Impact factor: 4.359

4. 15-year longitudinal study of blood pressure and dementia.

Authors: I Skoog; B Lernfelt; S Landahl; B Palmertz; L A Andreasson; L Nilsson; G Persson; A Odén; A Svanborg
Journal: Lancet Date: 1996-04-27 Impact factor: 79.321

5. The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons.

Authors: M N Haan; L Shemanski; W J Jagust; T A Manolio; L Kuller
Journal: JAMA Date: 1999-07-07 Impact factor: 56.272

6. Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis.

Authors: S Hoyer
Journal: J Neural Transm (Vienna) Date: 1998 Impact factor: 3.575

Review 7. Diabetes trends in Europe.

Authors: Philippe Passa
Journal: Diabetes Metab Res Rev Date: 2002 Sep-Oct Impact factor: 4.876

8. Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study.

Authors: Zaldy Sy Tan; Sudha Seshadri; Alexa Beiser; Peter W F Wilson; Douglas P Kiel; Michael Tocco; Ralph B D'Agostino; Philip A Wolf
Journal: Arch Intern Med Date: 2003-05-12

9. Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Prospective studies collaboration.

Authors:
Journal: Lancet Date: 1995 Dec 23-30 Impact factor: 79.321

10. Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia.

Authors: L J Launer; K Andersen; M E Dewey; L Letenneur; A Ott; L A Amaducci; C Brayne; J R Copeland; J F Dartigues; P Kragh-Sorensen; A Lobo; J M Martinez-Lage; T Stijnen; A Hofman
Journal: Neurology Date: 1999-01-01 Impact factor: 9.910

31 in total

Review 1. Diabetes type II: a risk factor for depression-Parkinson-Alzheimer?

Authors: Peter Riederer; Jasmin Bartl; Gerd Laux; Edna Grünblatt
Journal: Neurotox Res Date: 2010-06-15 Impact factor: 3.911

2. Distinct modulation of voltage-gated and ligand-gated Ca2+ currents by PPAR-gamma agonists in cultured hippocampal neurons.

Authors: Tristano Pancani; Jeremiah T Phelps; James L Searcy; Michael W Kilgore; Kuey-Chu Chen; Nada M Porter; Olivier Thibault
Journal: J Neurochem Date: 2009-05-11 Impact factor: 5.372

3. Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis.

Authors: R A Marrie; R Rudick; R Horwitz; G Cutter; T Tyry; D Campagnolo; T Vollmer
Journal: Neurology Date: 2010-03-30 Impact factor: 9.910

4. Risk perception and preference for prevention of Alzheimer's disease.

Authors: Sukyung Chung; Kala Mehta; Martha Shumway; Jennifer Alvidrez; Eliseo J Perez-Stable
Journal: Value Health Date: 2009-01-12 Impact factor: 5.725

5. Effect of high-fat diet on metabolic indices, cognition, and neuronal physiology in aging F344 rats.

Authors: Tristano Pancani; Katie L Anderson; Lawrence D Brewer; Inga Kadish; Chris DeMoll; Philip W Landfield; Eric M Blalock; Nada M Porter; Olivier Thibault
Journal: Neurobiol Aging Date: 2013-03-29 Impact factor: 4.673

6. Memory advancement by intranasal insulin in type 2 diabetes (MemAID) randomized controlled clinical trial: Design, methods and rationale.

Authors: B Galindo-Mendez; J A Trevino; R McGlinchey; C Fortier; V Lioutas; P Novak; C S Mantzoros; L Ngo; V Novak
Journal: Contemp Clin Trials Date: 2020-01-07 Impact factor: 2.226

Review 7. Insulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis.

Authors: Suzanne M de la Monte; Lisa Longato; Ming Tong; Jack R Wands
Journal: Curr Opin Investig Drugs Date: 2009-10

8. The impact of vascular comorbidities on qualitative error analysis of executive impairment in Alzheimer's disease.

Authors: Melissa Lamar; David J Libon; Angela V Ashley; James J Lah; Allan I Levey; Felicia C Goldstein
Journal: J Int Neuropsychol Soc Date: 2009-10-19 Impact factor: 2.892

9. Alzheimer's disease is type 3 diabetes-evidence reviewed.

Authors: Suzanne M de la Monte; Jack R Wands
Journal: J Diabetes Sci Technol Date: 2008-11

10. Hepatic ceramide may mediate brain insulin resistance and neurodegeneration in type 2 diabetes and non-alcoholic steatohepatitis.

Authors: Lascelles E Lyn-Cook; Margot Lawton; Ming Tong; Elizabeth Silbermann; Lisa Longato; Ping Jiao; Princess Mark; Jack R Wands; Haiyan Xu; Suzanne M de la Monte
Journal: J Alzheimers Dis Date: 2009 Impact factor: 4.472